Clinacox™ and BMD®

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 141153
  • Animal drug product ID 310

What the source publishes

Holder
Elanco US Inc.
Active ingredients
Bacitracin methylenedisalicylate Diclazuril
Form
Medicated Feed
Routes
Oral
Supply regime
OTC

Names this record is found by

Complete source data
us:fda:animaldrugs:253:310
{
  "form": "Medicated Feed",
  "name": "Clinacox™ and BMD®",
  "holder": "Elanco US Inc.",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "OTC",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Chickens:430": "Broilers not laying eggs for human consumption"
    },
    "sortOrder": 0,
    "withdrawals": [
      "<p>No withdrawal period is required when used according to labeling. Do not feed to birds producing eggs for human consumption.</p>"
    ],
    "doseFormName": "Medicated Feed",
    "applicationId": null,
    "specifications": "Diclazuril: Type A medicated article in a concentration of 0.91 grams diclazuril activity per pound. \r\nBacitracin methylene disalicylate: Type A medicated article in concentrations of 10, 25, 30, 50, 60, or 75 grams of bacitracin activity per pound.",
    "proprietaryName": "Clinacox™ and BMD®",
    "proprietaryNameId": 310,
    "statusDescription": "OTC"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2020-07-17",
    "sponsorName": "Elanco US Inc.",
    "applicationId": 253,
    "applicationType": "N",
    "proprietaryName": "Clinacox™ and BMD®\n",
    "applicationNumber": 141153,
    "activeIngredientName": "Bacitracin methylenedisalicylate\nDiclazuril\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "430",
      "label": "Chickens",
      "native": {
        "key": "Chickens:430",
        "population": "Broilers not laying eggs for human consumption"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Broilers not laying eggs for human consumption",
      "canonicalId": "chicken",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2020-07-17",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [
    {
      "native": "<p>No withdrawal period is required when used according to labeling. Do not feed to birds producing eggs for human consumption.</p>",
      "status": "unparsed"
    }
  ],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 253,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Bacitracin methylenedisalicylate\nDiclazuril\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Diclazuril",
      "activeIngredientTolerance": "<p>(1) Chickens</p>\r\n<p>(i) Liver. The tolerance for parent diclazuril (the marker residue) is 3 parts per million (ppm).</p>\r\n<p>(ii) Muscle. The tolerance for parent diclazuril (the marker residue) is 0.5 ppm.</p>\r\n<p>(iii) Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 ppm.</p>\r\n<p>(2) Turkeys</p>\r\n<p>(i) Liver. The tolerance for parent diclazuril (the marker residue) is 3 ppm.</p>\r\n<p>&nbsp;(ii) Muscle. The tolerance for parent diclazuril (the marker residue) is 0.5 ppm.</p>\r\n<p>&nbsp;(iii) Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 ppm.</p>"
    },
    {
      "activeIngredientName": "Bacitracin methylenedisalicylate",
      "activeIngredientTolerance": null
    }
  ],
  "nativeApplicationNumber": 141153,
  "nativeProprietaryNameId": 310,
  "restrictionObservations": [
    {
      "indicationText": "For the prevention of coccidiosis caused by <i>Eimeria necatrix</i>, <i>E. tenella</i>, <i>E. acervulina</i>, <i>E. brunetti</i>, <i>E. mitis</i> (<i>mivati</i>), and <i>E. maxima</i>. Because diclazuril is effective against <i>E. maxima</i> later in its life cycle, subclinical intestinal lesions may be present for a short time after infection. Diclazuril was shown in studies to reduce lesion scores and improve performance and health of birds challenged with <i>E. maxima</i>. For increased rate of weight gain and improved feed efficiency in broiler chickens.",
      "limitationText": null,
      "populationText": "Broiler Chickens"
    }
  ],
  "withdrawalPeriodsStatus": "reported-unparsed",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:253:310"